Mckinsey & Company, Inc.

New York, NY Professional servicesNAICS 541600

Self-funded health planPlan year 2025Renews January
13,719Participants-5% vs. prior year
$32.5MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#2 of 70Professional services in NYBy participants

Overview

Mckinsey & Company, Inc. sponsors a self-funded health plan that covered 13,719 participants in plan year 2025, down 5% from the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, prepaid legal, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
13,719 · prior year 14,466
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
The International Regular Members Medical & Dental Plans of Mckinsey & Company, Inc., plan 511 (13,719 participants); The US Regular Members Medical & Dental Plans of Mckinsey & Company, Inc., plan 501 (12,197 participants); The Mckinsey Health Care Reimbursement Plan, plan 509 (2,722 participants)
Broker compensation
$1.4M across insured contracts
MedicalLife insuranceDentalVisionPrepaid legalLong-term disabilityDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Cigna Health and Life Insurance Company and AffiliatesMedical, Dental4,563$71.8M$499K
First Unum Life Insurance CompanyLong-term disability28,142$24.1M$475K
Metropolitan Life Insurance CompanyLife14,183$10.3M$360K
Cigna Health and Life Insurance CompanyMedical, Dental, Prescription drug, Vision33,595$5.4M—
Equitable Life Insurance CompanyLife705$1.8M$54K
Federal Insurance CompanyAccidental Death8,167$619K—
Metropolitan General Insurance CompanyLegal1,895$355K$59K
Delaware American Life Insurance CompanyLife258$241K—
Ace American Insurance CompanyBusiness Travel Accident37,290$161K—

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$32.5M/ year

Estimated prescription spend: 13,719 participants × $2,371 national average per member. Usually higher once dependents are counted.

$846K–$2.1M/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$247K–$618K
Lower-cost therapeutic alternatives$361K–$755K
Generic pricing vs. actual cost$156K–$468K
PBM contract terms$81K–$244K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Mckinsey & Company, Inc.
Sponsor EIN
13-1826332
Plan numbers
511, 501, 509
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 13-1826332 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
Mckinsey & Company, Inc. (psrp) Profit Sharing Retirement Plan
Type
401(k) plan
Participants
35,692

About this data

Source: Mckinsey & Company, Inc.'s Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Mckinsey & Company, Inc..

Request a correction · Methodology